Pediatric
The Pediatric/Developmental Ophthalmology Service consists of the Division
of Pediatric/Developmental Ophthalmology and the Childrens Eye Medical
and Surgical Group at Childrens Hospital Los Angeles (CHLA), including
a program developed in association with CHLA, the Institute for Families
of Blind Children, as well as the Pediatric Ophthalmology Clinic as
the LAC+USC Medical Center, Outpatient Department. A full range of diagnostic
and treatment methodologies are available through Doheny's ancillary
and orthoptic service departments. Faculty members on this service have
modified a behavioral technique, Forced Preferential Looking (FPL),
for measuring visual acuity in infants and preverbal children. In addition
to offering the full range of pediatric ophthalmology care, this service
specializes in diagnosis and treatment of ocular oncology, neuro-ophthalmology,
retinal disorders and strabismus.
 |
Mark S. Borchert,
M.D.
Dr. Borchert earned an M.D. from Baylor College of Medicine. He
completed his residency at the Doheny Eye Institute, University
of Southern California and a fellowship at the Massachusetts Eye
& Ear Infirmary, Harvard University. Dr. Borchert specializes
in Pediatric Neuro-Ophthalmology. His research on the development
of the retina and optic nerve in rats was part of a recent experiment
on the NASA space shuttle. Dr. Borchert is an Associate Professor
at the USC Keck School of Medicine. |
| |
|
 |
Talia Kolin
Dr. Kolin earned an M.D. From Mount Sinai School of Medicine,
New York, New York. She completed her residency at White Memorial
Medical Center, Los Angeles, California, and her fellowship at
Childrens Hospital of Los Angeles.
|
| |
|
 |
A. Linn Murphree, M.D.
Dr. Murphree earned an M.D. from Baylor College of Medicine.
He completed three fellowships: one at the University of Copenhagen,
another at Baylor College of Medicine, and the third at Wilmer
Ophthalmological Institute, Johns Hopkins Hospital. Dr. Murphree
is a Professor of Ophthalmology and Pediatrics at the USC Keck
School of Medicine and leads the development of a world-class
Ocular Oncology Service at Childrens Hospital of Los Angeles and
at the Doheny Eye Institute. Dr. Murphree and his colleagues have
also developed new protocols for the treatment of retinoblastoma.
He co-chairs the Retinoblastoma Study (RBS), a planned international
multicenter clinical trial.
|
| |
|
 |
Jonathan Song, M.D.
Dr. Song earned an M.D. from University of California San Francisco.
He completed his residency at University of Southern California
/ Doheny Eye Institute. He also served as chief resident during
his residency. He completed two fellowships: a fellowship in pediatric
ophthalmology at Childrens Hospital Los Angeles and a fellowship
in Comea / Refractive Surgery at Doheny Eye Institute.
|
|